Quantcast
Last updated on April 24, 2014 at 21:24 EDT
Single Cell Type Found To Cause Most Invasive Bladder

Single Cell Type Found To Cause Most Invasive Bladder Cancers: Study

Lawrence LeBlond for redOrbit.com - Your Universe Online Invasive bladder cancer (IBC), a malignant disease that currently affects more than 375,000 people worldwide, has been found to be caused by a single type of cell in the lining of the...

Latest Oncology Stories

2014-04-24 16:29:10

Expanded indication makes cobas® HPV Test the only test approved in U.S. that can be used instead of Pap in first-line primary screening in women 25 and older PLEASANTON, Calif., April 24, 2014 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY)announced today that the U.S. Food and Drug Administration (FDA) approved the cobas(®) HPV (Human Papillomavirus) Test for use as a first-line primary screening test for cervical cancer in women 25 and older. The approval follows the March 12...

2014-04-24 12:54:13

Rates for all other cancers, except female lung cancer, continue to fall Pancreatic cancer is the only cancer for which deaths are predicted to increase in men and women rather than decrease in 2014 and beyond, according to a comprehensive study published in the leading cancer journal Annals of Oncology today (Thursday). The study by researchers in Italy and Switzerland shows that the proportion of deaths due to any sort of cancer is expected to fall overall in Europe in 2014. There are...

2014-04-24 12:29:13

Varian to deploy standardized treatment systems at UnityPoint Health hospitals across Iowa and Illinois PALO ALTO, Calif., April 24, 2014 /PRNewswire/ -- Varian Medical Systems (NYSE:VAR) announced that it has entered an agreement with UnityPoint Health to be its exclusive supplier of software and devices for image-guided radiotherapy and radiosurgery. The agreement is part of a long-term plan for enhancing and extending radiotherapy and radiosurgery cancer treatment capabilities...

2014-04-24 10:55:15

The American Society for Radiation Oncology (ASTRO) has issued a new guideline, “The Role of Postoperative Radiation Therapy for Endometrial Cancer: An ASTRO Evidence-Based Guideline,” that details the use of adjuvant radiation therapy in the treatment of endometrial cancer. The guideline’s executive summary is published in the May-June 2014 issue of Practical Radiation Oncology (PRO), the official clinical practice journal of ASTRO. The full-length guideline is available as an...

2014-04-24 08:33:57

Leading Cancer Immunotherapy Startup also Bolsters Leadership Team with Two Key Appointments SEATTLE, April 24, 2014 /PRNewswire-USNewswire/ -- Juno Therapeutics, a biotechnology company focused on bringing forward novel immunotherapies for cancer, today announced the close of its Series A round with $176M in fully committed funds. http://photos.prnewswire.com/prnvar/20140113/DC45426LOGO Juno's initial funding of $120 million came predominantly from leading technology venture...

2014-04-23 23:10:18

According to a new Korean study, a new method of diagnosing bladder cancer could “augment or replace” current approaches. Raleigh, NC (PRWEB) April 23, 2014 Cancer researchers in Korea say they have developed a simpler and less invasive way to diagnose bladder cancer from a urine sample. Details of the new study have just been posted on the Cancer Monthly website. Click here to learn more. Scientists with the Natural Product Research Institute at Seoul National University have...

2014-04-23 16:30:09

DUBLIN, April 23, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/3mgfnj/acute) has announced the addition of the "Acute Lymphocytic/Lymphoblastic Leukemia Therapeutics Market - Pipeline Forecast & Market Forecast in G8 Countries (2011 - 2020)" [http://www.researchandmarkets.com/research/3mgfnj/acute ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The acute...

2014-04-23 16:29:46

MARINA DEL REY, Calif., April 23, 2014 /PRNewswire/ -- Join Prostate Oncology Specialists for an educational talk about PROVENGE - a treatment to stimulate the immune system for advanced prostate cancer. Prostate cancer specialist, Dr. Jeffrey Turner, presents and reviews key topics: Why PROVENGE might be right for me? How do I know the PROVENGE treatment is working?How is PROVENGE different from hormone or chemotherapy?Does PROVENGE affect my PSA?How does PROVENGE boost my immune...

2014-04-23 12:30:36

LONDON, April 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Human papillomavirus (HPV) Associated Cancer Global Clinical Trials Review, H1, 2014http://www.reportbuyer.com/pharma_healthcare/drug_discovery/human_papillomavirus_hpv_associated_cancer_global_clinical_trials_review_h1_2014.html Human papillomavirus (HPV) Associated Cancer Global Clinical Trials Review, H1, 2014 SummaryGlobalData's clinical trial report, "Human papillomavirus (HPV)...

2014-04-23 08:31:41

- Investigators to Present Clinical Trial Findings Evaluating Compounds in Multiple Tumor Types NORTH CHICAGO, Ill., April 23, 2014 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that data evaluating a number of investigational compounds in the company's oncology pipeline will be presented at the upcoming 50(th) Annual Meeting of the American Society of Clinical Oncology (ASCO), May 30 - June 3, in Chicago. "Our clinical trial program underscores our commitment to developing innovative...